Carr G, Dougan M, Brooks P M, Maycock S
Curr Med Res Opin. 1982;8(3):197-9. doi: 10.1185/03007998209112383.
Indomethacin is commonly prescribed at night to relieve morning stiffness in patients with rheumatoid arthritis. Pharmacokinetic and pharmacodynamic interactions are frequently described with non-steroidal anti-inflammatory drugs, and the rationale of using more than one of these agents at the same time is questionable. A randomized crossover trial was carried out in 14 patients to compare the effects of 100 mg indomethacin at night with those of placebo when added to a baseline regimen of stabilized salicylate therapy with a slow-release preparation. Each treatment was given for 2 weeks. The results suggest that the addition of indomethacin produced no significant benefit in terms of reduction in the duration of morning stiffness or on the overall daily pain score.
吲哚美辛通常在夜间给药,以缓解类风湿性关节炎患者的晨僵症状。非甾体抗炎药之间经常出现药代动力学和药效学相互作用,同时使用一种以上这类药物的合理性值得怀疑。对14名患者进行了一项随机交叉试验,比较在稳定的水杨酸缓释制剂基线治疗方案基础上,夜间服用100毫克吲哚美辛与服用安慰剂的效果。每种治疗持续2周。结果表明,添加吲哚美辛在缩短晨僵持续时间或总体每日疼痛评分方面没有显著益处。